CLINICAL-STUDIES WITH TNF

被引：20

作者：

TAGUCHI, T

SOHMURA, Y

机构：

[1] OSAKA UNIV,MICROBIAL DIS RES INST,DEPT SURG,SUITA,OSAKA 565,JAPAN

[2] DAINIPPON PHARMACEUT CO LTD,RES LABS,DEPT IMMUNOL,SUITA,OSAKA 564,JAPAN

来源：

BIOTHERAPY | 1991年 / 3卷 / 02期

关键词：

ANTITUMOR RESPONSE; CLINICAL TRIALS; PHARMACOKINETICS; TOXICITY; TUMOR NECROSIS FACTOR;

D O I：

10.1007/BF02172090

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

页码：177 / 186

页数：10

共 41 条

[1]

ABBRUZZESE JL, 1989, CANCER RES, V49, P4057

[2]

BARTSCH H H, 1988, Molecular Biotherapy, V1, P21

[3] INTRALESIONAL APPLICATION OF RECOMBINANT HUMAN-TUMOR NECROSIS FACTOR-ALPHA INDUCES LOCAL TUMOR-REGRESSION IN PATIENTS WITH ADVANCED MALIGNANCIES [J].

BARTSCH, HH ;

PFIZENMAIER, K ;

SCHROEDER, M ;

NAGEL, GA .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (02) :287-&

[4]

BEUTLER B, 1987, NEW ENGL J MED, V316, P379

[5]

BLICK M, 1987, CANCER RES, V47, P2986

[6] ENDOTOXIN-INDUCED SERUM FACTOR THAT CAUSES NECROSIS OF TUMORS [J].

CARSWELL, EA ;

OLD, LJ ;

KASSEL, RL ;

GREEN, S ;

FIORE, N ;

WILLIAMSON, B .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (09) :3666-3670

[7] CLINICAL-PHARMACOLOGY OF RECOMBINANT HUMAN-TUMOR NECROSIS FACTOR IN PATIENTS WITH ADVANCED CANCER [J].

CHAPMAN, PB ;

LESTER, TJ ;

CASPER, ES ;

GABRILOVE, JL ;

WONG, GY ;

KEMPIN, SJ ;

GOLD, PJ ;

WELT, S ;

WARREN, RS ;

STARNES, HF ;

SHERWIN, SA ;

OLD, LJ ;

OETTGEN, HF .

JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (12) :1942-1951

[8]

CREAGAN ET, 1988, CANCER, V62, P2467, DOI 10.1002/1097-0142(19881215)62:12<2467::AID-CNCR2820621202>3.0.CO

[9]

2-5

[10]

CREASEY AA, 1986, CANCER RES, V46, P5687

← 1 2 3 4 5 →